Table 1:

Vertebroplasty patient and procedure characteristics

AllType of PainP ValuePain MedicationP Value
SevereNonsevereGivenNot Given
No. patients42969360133296
Patient characteristics
    Age (median, IQR)75 (65–82)75 (65–82)75 (65–83).9975 (65–83)75 (65–82).66
    Female (%)257 (40)41 (59)216 (60).9988 (66)169 (57).09
    No. with chronic, untreated fractures (%)142 (33)27 (39)115 (32).2759 (44)83 (28).0012
    No. with fractures because of malignancy (%)74 (18)15 (24)59 (17).2125 (20)49 (18).49
    Median VAS rest pain score (IQR)4 (1–6)5 (2–7)3 (1–6).02083 (1–6)4 (1–6).54
    Median VAS activity pain score (IQR)9 (7–10)10 (8–10)8 (7–10).026310 (8–10)9 (7–10).0022
    Median pain duration (months, IQR)2 (1–4)2 (1–3)2 (1–4).761 (1–3)2 (1–4).0317
    No. receiving pain medication (%)401 (99)60 (98)341 (99).56126 (99)275 (99).99
    Median pain medication score (IQR)3 (3–3)3 (3–3)3 (3–3).853 (3–3)3 (3–3).0058
Vertebroplasty procedure characteristics
    Median cement volume (mL) (IQR)3.5 (2.0–5.0)3.5 (2.0–5.0)3.2 (2.0–4.6).883.7 (2.0–5.0)3.0 (2.0–4.5).15
    Unilateral needle placement (%)306 (77)46 (74)260 (78).5189 (75)217 (78).51
    Median no. levels treated (IQR)1 (1–2)1 (1–2)1 (1–2).841 (1–2)1 (1–2).28
    3+ levels treated (%)48 (11)11 (16)37 (10).2122 (17)26 (9).0205
    Complications (%)95 (23)17 (25)78 (22).7530 (23)65 (22).99
    Cement embolus (%)19 (4)4 (6)15 (4).537 (5)12 (4).62
    Extravertebral leakage (%)75 (17)12 (18)63 (18).8722 (17)53 (18).89